BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol. 2013;44:2792-2798. [PMID: 24139211 DOI: 10.1016/j.humpath.2013.07.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kinoshita S, Sho M, Enomoto Y, Koyama F, Akahori T, Nagai M, Ito M, Morita K, Ohbayashi C, Nakajima Y. SALL4 positive fetal gut-like adenocarcinoma of the duodenum: Fetal gut-like carcinoma of the duodenum. Pathol Int 2014;64:581-4. [DOI: 10.1111/pin.12211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ostwal V, Harris C, Sirohi B, Goel M, Bal M, Kannan S, Shrikhande SV. Role of adjuvant chemotherapy in T2N0M0 periampullary cancers. Asia-Pac J Clin Oncol 2017;13:e298-303. [DOI: 10.1111/ajco.12612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tesarikova J, Skalicky P, Kurfurstova D, Svebisova H, Urban O, Falt P, Zapletalova J, Klos D, Lovecek M. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34012147 DOI: 10.5507/bp.2021.028] [Reference Citation Analysis]
4 Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V. Non-ampullary–duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Mod Pathol 2017;30:255-66. [DOI: 10.1038/modpathol.2016.174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
5 Yoshida T, Kojima Y, Shimada R, Tanabe H, Tabei K, Yanagida O, Nikaido T, Ohtsuka K, Ohnishi H, Abe N, Hisamatsu T, Takahashi S. Next-Generation Sequencing for Non-Ampullary Duodenal Carcinoma Suggesting the Existence of an Adenoma-Carcinoma Sequence. Case Rep Gastroenterol 2021;15:62-9. [PMID: 33613165 DOI: 10.1159/000510919] [Reference Citation Analysis]
6 Requejo Rodriguez E, Montet X, Fournier I, Morel P, Puppa G. Ampullary micropapillary adenocarcinoma widely metastatic to the lymph nodes: A case report. Human Pathology: Case Reports 2018;14:12-5. [DOI: 10.1016/j.ehpc.2018.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Yang CW, Liu XJ, Liu SY, Wan S, Ye Z, Song B. Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor Imaging. Contrast Media Mol Imaging 2020;2020:6058159. [PMID: 33304203 DOI: 10.1155/2020/6058159] [Reference Citation Analysis]
8 Lu J, Hu D, Tang H, Hu X, Shen Y, Li Z, Peng Y, Kamel I. Assessment of tumor heterogeneity: Differentiation of periampullary neoplasms based on CT whole-lesion histogram analysis. Eur J Radiol. 2019;115:1-9. [PMID: 31084752 DOI: 10.1016/j.ejrad.2019.03.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hirashita T, Ohta M, Tada K, Saga K, Takayama H, Endo Y, Uchida H, Iwashita Y, Inomata M. Prognostic factors of non-ampullary duodenal adenocarcinoma. Jpn J Clin Oncol 2018;48:743-7. [PMID: 29931295 DOI: 10.1093/jjco/hyy086] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415 [PMID: 29085567 DOI: 10.4251/wjgo.v9.i10.407] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ohtsuka M, Miyazaki M. Long-Term Survival After Resection of Periampullary Cancer. In: Beger HG, Warshaw AL, Hruban RH, Büchler MW, Lerch MM, Neoptolemos JP, Shimosegawa T, Whitcomb DC, Groß C, editors. The Pancreas. Chichester: John Wiley & Sons, Ltd; 2018. pp. 1097-106. [DOI: 10.1002/9781119188421.ch146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhu Z, Zhong F. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis. Cancer Invest 2020;38:543-8. [PMID: 33073637 DOI: 10.1080/07357907.2020.1824260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Guo R, Overman M, Chatterjee D, Rashid A, Shroff S, Wang H, Katz MH, Fleming JB, Varadhachary GR, Abbruzzese JL, Wang H. Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. Hum Pathol 2014;45:1015-23. [PMID: 24746206 DOI: 10.1016/j.humpath.2013.12.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wilhelm A, Galata C, Beutner U, Schmied BM, Warschkow R, Steffen T, Brunner W, Post S, Marti L. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis. J Surg Oncol 2018;117:397-408. [DOI: 10.1002/jso.24877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]